Japanese researcher Shimon Sakaguchi, one of the three winners of this year’s Nobel Prize in Physiology or Medicine, has ...

Fondazione Telethon ETS' Waskyra has become the first gene therapy in the US for patients with Wiskott-Aldrich syndrome (WAS) ...

Ocular immunology investigates the complex interplay between molecular mediators and immune cells responsible for maintaining ocular immune privilege, as ...

The U.S. Food and Drug Administration said on Tuesday it had approved the first gene therapy for a rare and life-threatening ...

NEW YORK – A gene therapy using lentiviral particles to generate CAR T cells inside multiple myeloma patients has shown the ability to eliminate the small number of cancer cells in the bone marrow ...

The immunotherapies used to treat melanoma now include well-established drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) and newer ones such as Amtagvi (lifileucel), which uses T cells ...

“In our real-world experience, [Yescarta] in relapsed or refractory follicular lymphoma showed durable responses and a ...

Because of NextCell’s algorithm that allows optimized donor choice for MSC production, its therapy could be completely ...

The addition of ianalumab to eltrombopag significantly improved outcomes for patients with pretreated primary immune ...

Two years after this, Sakaguchi was able to link these discoveries. He proved that the Foxp3 gene governs the development of ...

Patients who receive T-cell redirecting therapies are typically hospitalized for several days after treatment to watch for ...

Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard ...